| . "Translational Breast Cancer Research Consortium (TBCRC) 022: A phase II trial of Neratinib for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases.." J Clin Oncol. 2016;34(9):945-52. Pub Med |
| . "Celecoxib with neoadjuvant chemotherapy for breast cancer might worsen outcomes differentially by COX-2 expression and ER status: Exploratory analysis of the REMAGUS02 trial.." J Clin Oncol. 2019;37(8):624-635. Pub Med |
| . "Network meta-analysis of margin threshold for women with ductal carcinoma in situ.." J Natl Cancer Inst. 2012;104(7):507-16. Pub Med |
| . "Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial.." Lancet Oncol. 2017;18(6):732-742. Pub Med |
| . "Proportional exponentiated link transformed hazards (ELTH) models for discrete time survival data with application.." Lifetime Data Anal. 2016;22(1):38-62. Pub Med |
| . "The association between copy number aberration, DNA methylation and gene expression in tumor samples.." Nucleic Acids Res. 2018;46(6):3009-3018. Pub Med |
| . "A comparison of proposed biosimilar LA-EP2006 and reference Pegfilgrastim for the prevention of neutropenia in patients with early-stage breast cancer receiving Myelosuppressive adjuvant or Neoadjuvant chemotherapy: Pegfilgrastim Randomized Oncology (Supp." Oncologist. 2016;21(7):789-94. Pub Med |
| . "Pharmacogenetics, enzyme probes and therapeutic drug monitoring as potential tools for individualizing taxane therapy.." Pharmacogenomics. 2013;14(5):555-74. Pub Med |
| . "PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation.." Sci Transl Med. 2016;8(369):369ra175. Pub Med |
| . "Sample size and power determination in joint modeling of longitudinal and survival data.." Stat Med. 2011;30(18):2295-309. Pub Med |
| . "Multiple testing of treatment-effect-modifying biomarkers in a randomized clinical trial with a survival endpoint.." Stat Med. 2011;30(13):1502-18. Pub Med |
| . "An Expectation Maximization algorithm for fitting the generalized odds-rate model to interval censored data.." Stat Med. 2017;36(7):1157-1171. Pub Med |
| . "Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial.." Lancet Oncol. 2017;18(6):732-742. Pub Med |
| . "Intergenerational response to the endocrine disruptor vinclozolin is influenced by maternal genotype and crossing scheme.." Reprod Toxicol. 2018;78():9-19. Pub Med |
| . "Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial.." Lancet Oncol. 2017;18(6):732-742. Pub Med |
| . "Pharmacogenetics, enzyme probes and therapeutic drug monitoring as potential tools for individualizing taxane therapy.." Pharmacogenomics. 2013;14(5):555-74. Pub Med |
| . "LIBERTI: A SMART study in plastic surgery.." Clin Trials. 2018;15(3):286-293. Pub Med |
| . "Marginal additive hazards model for case-cohort studies with multiple disease outcomes: an application to the Atherosclerosis Risk in Communities (ARIC) study.." Biostatistics. 2013;14(1):28-41. Pub Med |
| . "Assessing the dependence of sensitivity and specificity on prevalence in meta-analysis.." Biostatistics. 2011;12(4):710-22. Pub Med |
| . "Robust test method for time-course microarray experiments.." BMC Bioinformatics. 2010;11():391. Pub Med |
| . "A precision medicine approach to develop and internally validate optimal exercise and weight loss treatments for overweight and obese adults with knee osteoarthritis.." Arthritis Care Res (Hoboken). 2021;73(5):693-701. Pub Med |
| . "Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial.." Lancet Oncol. 2017;18(6):732-742. Pub Med |
| . "Estimating effect of environmental contaminants on women's subfecundity for the MoBa study data with an outcome-dependent sampling scheme.." Biostatistics. 2014;15(4):636-50. Pub Med |
| . "Predictive blood-based biomarkers in patients with epithelial ovarian cancer treated with carboplatin and paclitaxel with or without bevacizumab: Results from GOG-0218.." Clin Cancer Res. 2020;26(6):1288-1296. Pub Med |
| . "Differences in race, molecular and tumor characteristics among women diagnosed with invasive ductal and lobular breast carcinomas.." Cancer Causes Control. 2019;30(1):31-39. Pub Med |
| . "Network meta-analysis of margin threshold for women with ductal carcinoma in situ.." J Natl Cancer Inst. 2012;104(7):507-16. Pub Med |
| . "Differences in race, molecular and tumor characteristics among women diagnosed with invasive ductal and lobular breast carcinomas.." Cancer Causes Control. 2019;30(1):31-39. Pub Med |
| . "Reinforcement learning strategies for clinical trials in nonsmall cell lung cancer.." Biometrics. 2011;67(4):1422-33. Pub Med |
| . "A general framework for studying genetic effects and gene-environment interactions with missing data.." Biostatistics. 2010;11(4):583-98. Pub Med |
| . "ROC curve estimation under test-result-dependent sampling.." Biostatistics. 2013;14(1):160-72. Pub Med |
| . "Radiomics analysis using stability selection supervised component analysis for right-censored survival data.." Comput Biol Med. 2020;124():103959. Pub Med |
| . "Enrollment trends and disparity among patients with lung cancer in national clinical trials, 1990 to 2012.." J Clin Oncol. 2016;34(33):3992-3999. Pub Med |
| . "Pooled analysis of individual patient data on concurrent chemoradiotherapy for stage III non-small-cell lung cancer in elderly patients compared with younger patients who participated in US National Cancer Institute Cooperative Group Studies.." J Clin Oncol. 2017;35(25):2885-2892. Pub Med |
| . "Clinical prognostic model for older patients with advanced non-small cell lung cancer.." J Geriatr Oncol. 2019;10(4):555-559. Pub Med |
| . "Risk calculators are useful but....." J Thorac Cardiovasc Surg. 2016;151(3):706-707. Pub Med |
| . "Toxicity related to radiotherapy dose and targeting strategy: A pooled analysis of cooperative group trials of combined modality therapy for locally advanced non-small cell lung cancer.." J Thorac Oncol. 2019;14(2):298-303. Pub Med |
| . "Validation of survival prognostic models for non-small-cell lung cancer in stage- and age-specific groups.." Lung Cancer. 2015;90(2):281-7. Pub Med |
| . "Predicting risk of chemotherapy-induced severe neutropenia: A pooled analysis in individual patients data with advanced lung cancer.." Lung Cancer. 2020;141():14-20. Pub Med |
| . "Predictive blood-based biomarkers in patients with epithelial ovarian cancer treated with carboplatin and paclitaxel with or without bevacizumab: Results from GOG-0218.." Clin Cancer Res. 2020;26(6):1288-1296. Pub Med |
| . "A novel test to compare two treatments based on endpoints involving both nonfatal and fatal events.." Pharm Stat. 2015;14(4):273-83. Pub Med |
| . "Pharmacogenomics as a risk mitigation strategy for chemotherapeutic cardiotoxicity.." Pharmacogenomics. 2013;14(2):205-13. Pub Med |
| . "A varying-coefficient generalized odds rate model with time-varying exposure: An application to fitness and cardiovascular disease mortality.." Biometrics. 2019;75(3):853-863. Pub Med |
| . "Bayesian meta-experimental design: evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes.." Biometrics. 2012;68(2):578-86. Pub Med |
| . "Modeling survival distribution as a function of time to treatment discontinuation: A dynamic treatment regime approach.." Biometrics. 2018;74(3):900-909. Pub Med |
| . "A general framework for association tests with multivariate traits in large-scale genomics studies.." Genet Epidemiol. 2013;37(8):759-67. Pub Med |
| . "Rare variants association analysis in large-scale sequencing studies at the single locus level.." PLoS Comput Biol. 2016;12(6):e1004993. Pub Med |
| . "Bayesian sequential meta-analysis design in evaluating cardiovascular risk in a new antidiabetic drug development program.." Stat Med. 2014;33(9):1600-18. Pub Med |
| . "A practical Bayesian adaptive design incorporating data from historical controls.." Stat Med. 2018;37(27):4054-4070. Pub Med |
| . "Quantifying center of pressure variability in chondrodystrophoid dogs.." Vet J. 2017;226():26-31. Pub Med |
| . "Diseased region detection of longitudinal knee magnetic resonance imaging data.." IEEE Trans Med Imaging. 2015;34(9):1914-27. Pub Med |
